DNA repair in cancer initiation, progression, and therapy—a double-edged sword

Alberg AJ, Jorgensen TJ, Ruczinski I, Wheless L, Shugart YY, Berthier-Schaad Y (2013) DNA repair gene variants in relation to overall cancer risk: a population-base study 34(1):86–92

Azevedo AP, Silva SN, Reicher A, Lima F, Junior E, Rueff J (2018) Effects of polymorphic DNA genes involved in BER and cascade pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea. Mol Med Rep 18:5243–5255

Bossi G, Saccho A (2007) Restoration of wild-type p53 function in human cancer: relevance for tumor therapy. Head Neck 29:272–284

Chakraborty U, Dinh TA, Alani E (2018) Genomic instability promoted by overexpression of mismatch repair factors in yeast. A model for understanding cancer progression. Genetics 209:439–456

Chen W, Wang ZY, Xu FL, Wu KW, Zhang Y, Xu L, Wang QP (2014) Association of XRCC1 genetic poilymorhism (Arg399Gln) with laryngeal cancer: a meta-analysis base on 4,031 subjects. Tumor Biol 35:1637–1640

Danoy P, Michiels S, Dessen P, Pignat C, Boulet T, Monet M, Bouchardy C, Lathrop M, Sarasin A, Benhamou S (2008) Variants in DNA double-strand break repair and DNA damage response genes and susceptibility to lung and head and neck cancers. Int J Cancer 123:457–463

Dupuy A, Sarasin A (2015) DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease. Mutat Res 776:2–8

Germano G, Amirouchene-Angelozzi N, Rospo G, Bardelli A (2018) The clinical impact of the genomic landscape of MMR-deficient cancers. Cancer Discov 8:1518–1528

Hanawalt P (2012) Repairing DNA for 80 years: the timeline of my life. DNA Repair 11:e452

Hosoya N, Miyagawa K (2014) Targeting DNA damage response in cancer therapy. Cancer Sci 2014:370–388

Jacobsen F, Taskin B, Melling N, Sauer C, Wittmer C, Hube-magg C et al (2017) Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer. BMC Cancer 17:e504

Kaina B, Izzotti A, Hu J, Christmann M, Pulliero A, Zhao X, Dobreanu M, Au WW (2018) Inherent and toxicant-provoked reduction in DNA repair capacity: a key mechanism for personalized risk assessment, cancer prevention and intervention, and response to therapy. Int J Hyg Environ Health 221:99301006

Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF et al (2018) Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas. Cell Rep 23:239–254

Li D, You HH, Jia YJ, Guo JD, Du HLE (2014) Association of C722T polymorphism in XRCC3 gene with larynx cancer: a meta-analysis. Tumor Biol 35:5427–5430

Li Q, Ma R, Zhang M (2018) XRCC1 rs 1799782 (C194T) polymorphism correlated with tumor metastasis and molecular subtypes in breast cancer. Onco Targets Ther 11:8435–8444

Loeb LA, Bielas JH, Beckman RA (2008) Cancers exhibit a mutator phenotype: clinical implications. Cancer Res 68:3551–3557

Longton E, Schmit K, Fransolet M, Clement F, Michiels C (2018) Appropriate sequence for afatinib and cisplatin combination improves anticancer activity in head and neck squamous cell carcinoma. Front Oncol 8:e432

Martin LP, Hamilton TC, Schilder RJ (2008) Platinum resistance: the role of DNA repair pathways. Clin Cancer Res 14:1291–1295

Milecki P, Szyfter K (2003) Prediction of radiotherapy effect based on evaluation of radiosensitivity of normal and cancer tissue – limitations and possibilities. Curr Oncol 7:339–345

Nejda N, Iglesias D, Azycoita MM, Arana VM, Gonzaley-Aguilera F-PAM (2009) A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer. Cancer Genet Cytogenet 193:71–77

Nickson CM, Moori P, Carter RJ, Rubbi CP, Parsons JL (2017) Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity. Oncotarget 8:29963–29975

Noda A (2018) Radiation induced unrepairable DSBs: their role in the late effects of radiation and possible applications to biodosimetry. J Radiat Res 59(suppl.2):ii114–ii120

Nogueira GAS, Dias Costa EF, Agular LL, Lima TRP, Visacri MB, Pincinato EC et al (2018) Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma. Oncotarget 9:29538-29-547

Peng H, Yao S, Dong Q, Zhang Y, Gong W, Jia Z, Yan L (2018) Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma. Medicine (Baltimore) 97:e11697

Poletto M, Legrand AJ, Fletcher SC, Dianov GL (2016) p53 coordinated base excision repair to prevent genomic instability. Nucleic Acids Res 44:3165–3175

Roos WP, Kaina B (2013) DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 332:237–248

Sakthivel KM, Hariharan S (2017) Regulatory players of DNA damage repair mechanisms: role in cancer chemoresistance. Biomed Pharmacother 93:1238–1245

Santana T, Sa MC, de Moura SE, Galvao HC, Coletta RD, Freitas RA (2016) DNA base excision repair proteins APE-1 and XRCC-1 are overexpressed in oral squamous cell carcinoma. J Oral Pathol Med 46:496–507

Sarasin A, Kauffmann A (2008) Overexpression of DNA repair genes is associated with metastasis. A new hypothesis. Mutat Res 659:49–55

Shafirovich V, Geacintov NE (2017) Removal of oxidatively generated DNA damage by overlapping repair pathways. Free Radic Biol Med 107:53–61

Shah SN, Hile SE, Eckert KA (2010) Defective mismatch repair, microsatellite mutation bias, and variability in clinical cancer phenotypes. Cancer Res 70:431–435

Smolarz B, Michalska MM, Samulak D, Romanowicz H, Wójcik L (2019) Polymorphism of DNA repair genes in breast cancer. Oncotarget 10:527–535

Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Review. Nature 9(458(7239)):719–724

Terasawa M, Shinohara A, Shinohar M (2014) Double-strand break repair-adox. Restoration of suppressed double-strand break repair during mitosis induces genomic instability. Cancer Sci 105:1519–1525

Tian H, Gao Z, LiHZ ZBF, Wang G, Zhang Q, Pei DS, Zheng J (2015) DNA damage response – a double-edged sword in cancer prevention and cancer therapy. Cancer Lett 358:8–16

Toulany M (2019) Targeting double-strand break repair pathways to improve radiotherapy response. Genes 1:e25

Uraki S, Ariyasu H, Doi A, Kawai S, Takeshima K, Morita S et al (2018) Reduced expression of mismatch repair genes MSH6/MSH2 directly promotes pituitary tumor growth via ATR-Chk1 pathway. J Clin Endocrinol Metab 103:1171–1179

Vodenkova S, Jiraskova K, Urbanova M, Kroupa M, Slyskova J, Scheiderova M et al (2018) Base excision repair capacity as a determinant of prognosis and therapy response in colon cancer patients. DNA Repair 72:77–85

Wang J, Guo C, Gong X, Ao F, Huang Y, Huang L et al (2017) The impacts of genetic polymorphisms in genes of base excision repair pathway on the efficacy and acute toxicities of (chemo)radiotherapy in patients with nasopharyngeal carcinoma. Oncotarget 8:78633–78641

Zhang R, Jia M, Xue H, Xu Y, Wang M, Zhu M, Sun M, Chang J, Wei Q (2017) Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based-therapy. Sci Rep 7:e10702